{"id":605065,"date":"2022-06-22T21:04:01","date_gmt":"2022-06-22T21:04:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=605065"},"modified":"2022-06-22T21:04:01","modified_gmt":"2022-06-22T21:04:01","slug":"pituitary-cancer-market-size-share-growth-and-forecast-to-2029-datamintelligence","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/pituitary-cancer-market-size-share-growth-and-forecast-to-2029-datamintelligence_605065.html","title":{"rendered":"Pituitary Cancer Market Size, Share, Growth, and Forecast to 2029 | DataMIntelligence"},"content":{"rendered":"
\n
\"Pituitary<\/a><\/div>\n
\n
DataM Intelligence<\/div>\n<\/div>\n<\/div>\n
The Global Pituitary Cancer Market is expected to grow at a high CAGR of 9.4% during the forecasting period (2022-2029).<\/div>\n

Market Overview<\/strong><\/p>\n

Pituitary cancer is characterized by abnormal growth in the pituitary gland. It affects the functioning of the pituitary gland and may cause an increased or decreased level of pituitary hormone secretions within the body. The small pituitary cancer treatment is accessible through noninvasive treatment or medicines. But, a large pituitary cancer treatment is challenging to treat because of its complex nature.<\/p>\n

 <\/p>\n

Download free sample @ https:\/\/www.datamintelligence.com\/download-sample\/pituitary-cancer-market<\/a><\/em><\/strong><\/p>\n

 <\/strong><\/p>\n

Market Dynamics<\/strong><\/p>\n

The major driving forces are the rising incidence of pituitary cancers, increasing investments in research and development activities in pituitary cancer, growing technological advancements in pituitary cancer treatment, and increasing demand for non-invasive surgery.<\/p>\n

The rising incidence of pituitary cancer is expected to boost the market over the period of forecast. For instance, according to the National Brain Tumor Society, in 2018, 78,980 new cases of non-malignant, primary malignant and other central-nervous-system tumors are diagnosed in the US. Thus, the rising number of cases of brain tumors is expected to drive the pituitary cancer market during the forecast period.<\/p>\n

The increasing research and development activities related to pituitary cancer treatment are expected to boost the market. For instance, on July 31, 2019, Memorial Sloan Kettering Cancer Center has commenced a phase II study of nivolumab plus ipilimumab immunotherapy in patients with aggressive pituitary tumors, and the expected study completion date is July 2021. Thus, research and development activities are driving the market.<\/p>\n

However, the high treatment cost, lack of awareness, side effects, and stringent regulations may hamper the pituitary cancer market. Before and after surgery, the side effects of before and after surgery, like infection, bleeding, etc., may restrain the pituitary cancer market over the forecast period.<\/p>\n

 <\/p>\n

Market Segmentation<\/strong><\/p>\n

By Diagnosis<\/strong><\/p>\n